BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 37657859)

  • 1. Epigenetic inhibitors and their role in cancer therapy.
    Abdelaziz N; Therachiyil L; Sadida HQ; Ali AM; Khan OS; Singh M; Khan AQ; Akil ASA; Bhat AA; Uddin S
    Int Rev Cell Mol Biol; 2023; 380():211-251. PubMed ID: 37657859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
    Herranz M; Esteller M
    Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between different epigenetic modifications and mechanisms.
    Murr R
    Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenomics in stress tolerance of plants under the climate change.
    Kumar M; Rani K
    Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic modifications in gastric cancer: Focus on DNA methylation.
    Ebrahimi V; Soleimanian A; Ebrahimi T; Azargun R; Yazdani P; Eyvazi S; Tarhriz V
    Gene; 2020 Jun; 742():144577. PubMed ID: 32171825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting epigenetic regulations in cancer.
    Ning B; Li W; Zhao W; Wang R
    Acta Biochim Biophys Sin (Shanghai); 2016 Jan; 48(1):97-109. PubMed ID: 26508480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic dysregulation in cancer.
    Muntean AG; Hess JL
    Am J Pathol; 2009 Oct; 175(4):1353-61. PubMed ID: 19717641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Modulators as Treatment Alternative to Diverse Types of Cancer.
    Gutiérrez JR; Salgado ARM; Arias MÁ; San-Juan-Vergara H; Rada WR; Gómez CMM
    Curr Med Chem; 2022; 29(9):1503-1542. PubMed ID: 34963430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetics in cancer: targeting chromatin modifications.
    Ellis L; Atadja PW; Johnstone RW
    Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic regulation in human melanoma: past and future.
    Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
    Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic mechanisms in depression: Implications for pathogenesis and treatment.
    Chen HS; Wang F; Chen JG
    Curr Opin Neurobiol; 2024 Apr; 85():102854. PubMed ID: 38401316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic targeting for acute kidney injury.
    Zhuang S
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():21-25. PubMed ID: 30298650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress and promises of epigenetic drugs and epigenetic diets in cancer prevention and therapy: A clinical update.
    Mondal P; Natesh J; Penta D; Meeran SM
    Semin Cancer Biol; 2022 Aug; 83():503-522. PubMed ID: 33309850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review.
    Sahafnejad Z; Ramazi S; Allahverdi A
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Chromatin Remodeling for Cancer Therapy.
    Kaur J; Daoud A; Eblen ST
    Curr Mol Pharmacol; 2019; 12(3):215-229. PubMed ID: 30767757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation and chromatin remodeling in learning and memory.
    Kim S; Kaang BK
    Exp Mol Med; 2017 Jan; 49(1):e281. PubMed ID: 28082740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease.
    Bennett SA; Tanaz R; Cobos SN; Torrente MP
    Transl Res; 2019 Feb; 204():19-30. PubMed ID: 30391475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatin-remodelling mechanisms in cancer.
    Lafon-Hughes L; Di Tomaso MV; Méndez-Acuña L; Martínez-López W
    Mutat Res; 2008; 658(3):191-214. PubMed ID: 18403253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical Implications.
    Silverman BR; Shi J
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.